Official UK procurement notice
Gastrointestinal, Endocrine, Nutrition & Blood Medicines
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought15 lots · detail below
Published requirement descriptionThis Framework Agreement is for the supply of Gastrointestinal, Endocrine, Nutrition & Blood Medicines to health boards across NHS Scotland. The
Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 43 bids on the busiest of 14 lots · 46 suppliers appointed
Lots and requirements (15)Procurement structure
15 lots · all with a published value · same evaluation weights on every lotLot #1Desferoxamine InjectionsAwardedRenewalPublished value£481,192
Supply of Desferrioxamine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
Lot #2Dexamethasone InjectionsAwardedRenewalPublished value£484,394
Supply of Dexamethasone Injection to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #3Macrogol Oral Powder & SolutionsAwardedRenewalPublished value£4,658,289
Supply of Macrogol to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #4Mesalazine Oral/Rectal PreparationsAwardedRenewalPublished value£104,958
Supply of Mesalazine Oral/Rectal Preparations to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #5Magnesium Sulfate InjectionAwardedRenewalPublished value£181,511
Supply of Magnesium Sulfate Injection to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #6Colecalciferol & Calcium Carbonate TabletsAwardedRenewalPublished value£823,323
Supply of Colecalciferol & Calcium Carbonate Tablets to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #7Budesonide Oral/Rectal PreparationsAwardedRenewalPublished value£288,270
Supply of Budesonide Oral/Rectal Preparations to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #8Pancreatin CapsulesRenewalPublished value£959,663
Supply of Pancreatin Capsules to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #9Trientine TabletsAwardedRenewalPublished value£2,521,940
Supply of Trientine Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents.
Lot #10Teriparatide InjectionsAwardedRenewalPublished value£9,202,775
Supply of Teriparatide Injections to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per line to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Lot #11Tolvaptan TabletsAwardedRenewalPublished value£3,039,681
Supply of Tolvaptan Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents.
Lot #12Sapropterin & Deferasirox TabletsAwardedRenewalPublished value£738,821
Supply of Sapropterin & Deferasirox Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents.
Lot #13Intravenous (IV) IronAwardedRenewalPublished value£17,853,112
Supply of Intravenous (IV) Iron to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents.
Lot #14Diabetes & Weight ManagementAwardedRenewalPublished value£2,169,356
Supply of Diabetes & Weight Management to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents.
Lot #15All Other PresentationsAwardedRenewalPublished value£36,579,181
Supply of All Other Presentations to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per line . Full details of Goods and volumes can be found within the ITT documents.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Economic & financial standing
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL,PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender, should be included in the Qualification Envelope of the ITT under the T… - Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL,PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent at the date of submission of the tender.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the
climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender, should be included in the Qualification Envelope of the ITT under the T…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “Gastrointestinal, Endocrine, Nutrition & Blood Medicines” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 3 Mar 2025, 13:24 GMT
- Last source update
- 25 Jul 2025, 15:08 BST
- Award evaluation window
- 2 Apr 2025 – …
- Authority reference
NP39825- FTS notice number
2025/S 000-043203- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04e8f9Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information,
a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a
minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition
of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the twenty four (24) month contract duration and the twenty four (24) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 28651. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants/contractors agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework/contract. Potential framework participants/contractors are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants/contractors are required to summarise any proposed community benefits that will be developed and delivered as part of this framework/contract if successful or, alternatively, potential framework participants/contractors confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/). (SC Ref:804878)
How it was run
Official notice- Appointment period ends
- 2 Apr 2025, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 2 Apr 2025, 12:00 BST
Timeline
2 Apr 2025 → 25 Jul 2025 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown2 Apr 2025, 12:00 BST
- Bids opened2 Apr 2025, 12:00 BST
- Notice published25 Jul 2025, 15:08 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete25 Jul 2025, 15:08 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast14 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Desferoxamine Injections
- Signed
- 1 Jul 2025
- Value
- £263,956
- Status
- active
Sapropterin & Deferasirox Tablets
- Signed
- 1 Jul 2025
- Value
- £337,768
- Status
- active
Intravenous (IV) Iron
- Signed
- 1 Jul 2025
- Value
- £5,578,980
- Status
- active
Diabetes & Weight Management
- Signed
- 1 Jul 2025
- Value
- £355,196
- Status
- active
All Other Presentations
- Signed
- 1 Jul 2025
- Value
- £28,861,104
- Status
- active
Tolvaptan Tablets
- Signed
- 1 Jul 2025
- Value
- £1,610,268
- Status
- active
Dexamethasone Injections
- Signed
- 1 Jul 2025
- Value
- £437,276
- Status
- active
Mesalazine Oral/Rectal Preparations
- Signed
- 1 Jul 2025
- Value
- £110,204
- Status
- active
Magnesium Sulfate Injection
- Signed
- 1 Jul 2025
- Value
- £281,876
- Status
- active
Colecalciferol & Calcium Carbonate Tablets
- Signed
- 1 Jul 2025
- Value
- £668,436
- Status
- active
Budesonide Oral/Rectal Preparations
- Signed
- 1 Jul 2025
- Value
- £45,760
- Status
- active
Trientine Tablets
- Signed
- 1 Jul 2025
- Value
- £1,947,340
- Status
- active
Teriparatide Injections
- Signed
- 1 Jul 2025
- Value
- £5,380,700
- Status
- active
Macrogol Oral Powder & Solutions
- Signed
- 1 Jul 2025
- Value
- £3,075,648
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Desferoxamine Injections | 1bids · 1 electronic · 1 from abroad | 0 | — | — |
| 2 · Dexamethasone Injections | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 3 · Macrogol Oral Powder & Solutions | 3bids · 3 electronic · 3 from abroad | 1 | — | — |
| 4 · Mesalazine Oral/Rectal Preparations | 5bids · 5 electronic · 5 from abroad | 1 | — | — |
| 5 · Magnesium Sulfate Injection | 2bids · 2 electronic · 2 from abroad | 1 | — | — |
| 6 · Colecalciferol & Calcium Carbonate Tablets | 7bids · 7 electronic · 7 from abroad | 1 | — | — |
| 7 · Budesonide Oral/Rectal Preparations | 2bids · 2 electronic · 2 from abroad | 1 | — | — |
| 9 · Trientine Tablets | 3bids · 3 electronic · 3 from abroad | 1 | — | — |
| 10 · Teriparatide Injections | 5bids · 5 electronic · 5 from abroad | 1 | — | — |
| 11 · Tolvaptan Tablets | 4bids · 4 electronic · 4 from abroad | 1 | — | — |
| 12 · Sapropterin & Deferasirox Tablets | 6bids · 6 electronic · 6 from abroad | 1 | — | — |
| 13 · Intravenous (IV) Iron | 4bids · 4 electronic · 4 from abroad | 1 | — | — |
| 14 · Diabetes & Weight Management | 2bids · 2 electronic · 2 from abroad | 1 | — | — |
| 15 · All Other Presentations | 43bids · 43 electronic · 43 from abroad | 1 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
46 commercial parties on the notice- AccordFramework contractor
- Aventis Pharma Ltd t/a SanofiFramework contractor
- Baxter Healthcare LtdFramework contractor
- Brown and BurkFramework contractor
- CST Pharma LtdFramework contractor
- Colonis Pharma LtdFramework contractor
- Consilient Health LtdFramework contractor
- Crescent Pharma LimitedFramework contractor
- Dr Falk Pharma UK LtdFramework contractor
- Dr Reddy's Laboratories (UK) LtdFramework contractor
Show 36 more suppliers
- Ennogen Healthcare LtdFramework contractor
- Ferring Pharmaceuticals LimitedFramework contractor
- Flynn Pharma LtdFramework contractor
- Focus Pharmaceuticals LtdFramework contractor
- Galen LtdFramework contractor
- Gedeon Richter UK LtdFramework contractor
- Glenmark Pharmaceuticals Europe LtdFramework contractor
- Kent Pharmaceuticals LtdFramework contractor
- Kyowa Kirin International NewCo LtdFramework contractor
- Martindale PharmaFramework contractor
- Mercury Pharmaceuticals LimitedFramework contractor
- Morningside Pharmaceuticals LimitedFramework contractor
- Necessity Supplies LtdFramework contractor
- Norgine Pharmaceuticals LimitedFramework contractor
- Orphalan LtdFramework contractor
- Otsuka Pharmaceuticals (UK) LtdFramework contractor
- Panpharma UK LtdFramework contractor
- Pfizer LimitedFramework contractor
- Pharmacosmos UK LtdFramework contractor
- RPH Pharma LtdFramework contractor
- Ranbaxy (UK) LtdFramework contractor
- Rosemont Pharmaceuticals LtdFramework contractor
- SVP Pharma LtdFramework contractor
- Sandoz LtdFramework contractor
- Selective Supplies LtdFramework contractor
- Stirling Anglian Pharmaceuticals LtdFramework contractor
- Teva UK LtdFramework contractor
- Thornton & Ross LtdFramework contractor
- Typharm LtdFramework contractor
- Univar Solutions B.VFramework contractor
- Viatris UK Healthcare LtdFramework contractor
- Vifor Pharma UK LimitedFramework contractor
- Waymade PLCFramework contractor
- Wockhardt UK LimitedFramework contractor
- Zydus Pharmaceuticals UK LtdFramework contractor
- hameln pharma ltdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.